Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Pneumologie (Stuttgart, Germany)|December 11, 2023
[Palliative aspects in pulmonary oncology]David Heigener, Sandra DelisLung Cancer Management|January 16, 2019
Measurement of quality of life in second-line patients with advanced NSCLC without targetable mutations: a reviewDavid Heigener, Thomas KüchlerExpert Review of Anticancer Therapy|September 10, 2014
Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancerDavid Heigener, Martin ReckFuture Oncology (London, England)|February 18, 2016
Immunotherapy for small-cell lung cancer: emerging evidenceMartin Reck, David Heigener, Niels ReinmuthExpert Review of Clinical Pharmacology|August 15, 2014
Nintedanib for the treatment of patients with advanced non-small-cell lung cancerMartin Reck, David Heigener, Niels ReinmuthCurrent Opinion in Oncology|January 21, 2015
Novel angiogenesis inhibitors in nonsmall cell lung cancerNiels Reinmuth, David Heigener, Martin ReckLung Cancer (Amsterdam, Netherlands)|September 17, 2019
Immune checkpoint blockade in small cell lung cancerRebecca Y Tay, David Heigener, Martin Reck, et al.The Clinical Respiratory Journal|August 2, 2011
Efficacy and safety of bronchoscopic laser therapy in patients with tracheal and bronchial obstruction: a retrospective single institution reportAndreas Hermes, David Heigener, Ulrich Gatzemeier, et al.Expert Opinion on Drug Safety|December 9, 2010
Reviewing the safety of erlotinib in non-small cell lung cancerMartin Reck, Tony Mok, Jürgen Wolf, et al.Onkologie|October 10, 2009
Incidence of febrile neutropenia and myelotoxicity of chemotherapy: a meta-analysis of biosimilar G-CSF studies in breast cancer, lung cancer, and non-Hodgkin's lymphomaAndreas Engert, Auro del Giglio, Peter Bias, et al.Pageof 3